Cargando…
Late diagnosis of Fabry disease caused by a de novo mutation in a patient with end stage renal disease
BACKGROUND: We present the case of a white 35-year-old male with a diagnosis of Fabry disease and negative family history. CASE PRESENTATION: At the age of 31, he underwent a renal biopsy with a diagnosis of hypertension-induced nephroangiosclerosis. At the age of 35, he was referred to our hospital...
Autores principales: | Pisani, Antonio, Daniele, Aurora, Di Domenico, Carmela, Nigro, Ersilia, Salvatore, Francesco, Riccio, Eleonora |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4658750/ https://www.ncbi.nlm.nih.gov/pubmed/26602202 http://dx.doi.org/10.1186/s13104-015-1696-5 |
Ejemplares similares
-
Impact of COVID-19 pandemic on patients with Fabry disease: An Italian experience
por: Riccio, Eleonora, et al.
Publicado: (2020) -
Pain in Fabry Disease: Could Spinal Cord Stimulation be a Solution?
por: Buonanno, Pasquale, et al.
Publicado: (2023) -
Case report: De novo mutation of a-galactosidase A in a female patient with end-stage renal disease: report of a case of late diagnosis of Anderson–Fabry disease
por: Simonetta, Irene, et al.
Publicado: (2023) -
Agalsidase alfa and agalsidase beta in the treatment of Fabry disease: does the dose really matter?
por: Pisani, Antonio, et al.
Publicado: (2015) -
Molecular Diagnosis and Identification of Novel Pathogenic Variants in a Large Cohort of Italian Patients Affected by Polycystic Kidney Diseases
por: Nigro, Ersilia, et al.
Publicado: (2023)